The largest database of trusted experimental protocols

23 protocols using folic acid

1

Cell Culture of Common Cancer Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human lung cancer A549 cells and human cervical carcinoma HeLa cells were grown in Roswell Park Memorial Institute (RMPI) 1640 medium without folic acid (Thermo Fisher Scientific), and human L-O2 hepatocytes were cultured in RMPI 1640 medium with folic acid (Thermo Fisher Scientific). All media were supplemented with 10% fetal bovine serum (FBS) (Thermo Fisher Scientific), and cells were maintained at 37°C and 5% CO2 in a humidified incubator. HeLa, A549, and L-O2 hepatocytes were provided by the Chinese Academy of Cell Resource Center (Shanghai Institute of Biological Sciences, Chinese Academy of Sciences, Shanghai, People’s Republic of China).
+ Open protocol
+ Expand
2

Culturing Diverse Hematological Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
DC4 + human primary AML samples and normal peripheral blood mononuclear cells (PBMCs) were obtained from residual samples using a protocol approved by the Institutional Review Board of Stony Brook University. THP-1, U937, TALL104, and NK-92 cell lines were obtained from ATCC (Manassas, VA, USA). MOLM-13 was obtained from AddexBio (San Diego, CA, USA) T cells were cultured in filtered T cell media, defined as 50% AIM V, 40% RPMI 1640 and 10%FBS, with 1% Pen/Strep (all Gibco, Waltham, MA, USA) and supplemented with IL-2 (300 IU/mL; Peprotech, Rocky Hill, NJ, USA), unless otherwise specified. NK-92 cells were cultured in filtered NK cell media, defined as alpha-MEM without ribonucleosides and deoxyribonucleosides with 2mM L-glutamine, 1.5 g/L sodium bicarbonate (Gibco), 12.5% heat-inactivated horse serum (Gibco), 12.5% heat-inactivated FBS (Atlanta Biologicals, Atlanta GA, USA), 1% Pen/Strep (Gibco), 0.2% inositol (Sigma), 0.02% folic acid (Fisher), and 50 uM beta-mercaptoethanol (Fisher), supplemented with IL-2 (300 IU/mL), unless otherwise specified. THP-1, U937, and MOLM-13 cell lines were cultured in RPMI, 10% FBS, 1% Pen/Strep (Gibco). TALL104 cells were cultured in IMDM adding 300 IU/ml recombinant human IL-2, 2.5 mg/ml human albumin, 0.5 mg/ml D-mannitol, and 20% FBS.
+ Open protocol
+ Expand
3

Culturing Diverse Cell Lines and PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK-293T, Jurkat, and NK-92 cells were maintained at 37°C, 5% v/v CO2 in a humidified incubator. HEK-293T cells were maintained in DMEM (Corning) supplemented with 10% FBS (Sigma) and 1% Penicillin-Stretomycin (Corning). Jurkat cells were cultured in RPMI1640 (Lonza), 10% FBS, 1% Penicillin-Streptomycin. NK-92 cells were cultured in Alpha MEM without ribonucleosides and deoxyribonucleosides (Gibco) with 2 mM L-glutamine (Fisher), 1.5 g/l sodium bicarbonate (Sigma), 0.2 mM inositol (Sigma), 0.1 mM 2-mercaptoethanol, 0.02 mM folic acid (Fisher), 100U/ml recombinant IL-2 (Peprotech), 12.5% horse serum (Gibco) and 12.5% FBS (Corning). Cryopreserved human PBMCs were obtained from CTL Technologies and were. Cells were thawed in CTL test media and plated in RPMI1640 at a cell density of 1×106 cells/mL at 37° C and 5% CO2.
+ Open protocol
+ Expand
4

Characterization of NK92 Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
NK92, a human NK lymphoma cell line (CRL-2407) was obtained from ATCC. NK92 cells, expressing recombinant NKp46 or NKp46-IRES-GFP (designated as NK92.p46 or NK92.p46-IRES-GFP, respectively) were kindly provided by Kerry S Campbell (Fox Chase Cancer Center, Philadelphia, PA, USA). NK92 cell lines were grown in MEM Alpha medium (Gibco, Life Technologies), supplemented with heat-inactivated 10% horse serum, 10% FBS (Serum Source International), 0.2 mM myo-inositol (Sigma), 0.1 mM β-mercaptoethanol (Sigma) 0.02 mM folic acid (Fisher Scientific), 200 IU/mL of recombinant human IL-2 (eBioscience), and 50 IU/mL penicillin/streptomycin (Life Technologies) The following target cell lines were used HeLa, human cervical adenocarcinoma (ATCC CCL-2); HepG2, human hepatocellular carcinoma (ATCC HB-8065); 721.221, EBV-transformed human B-cell lymphoma. Cell lines were grown in a 5% CO2 humidified 37°C incubator and cultured in RPMI 1640 (Mediatech, Inc.) or DMEM (Gibco, Life Technologies) medium supplemented with 10% FBS and 1% penicillin/streptomycin. Antibodies that were used in this study were anti-human NKp46 PE or Biotin (Biolegend, clone 9E2), anti-human CD3 FITC (BD Pharmingen, clone UCHT1), and anti-human CD56 PE-Cy5 (BD Pharmingen, clone B159).
+ Open protocol
+ Expand
5

Pemetrexed Nanoparticle Synthesis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pemetrexed
disodium heptahydrate and poly-l-lysine hydrochloride (PLL;
15–30 kDa) were purchased
from Sigma Aldrich. Folic acid was purchased from Fisher Scientific.
All LbL methods were carried out in Milli-Q water from a Milli-Q source.
The KR2i TFF system was purchased from Spectrum Laboratories (Repligen,
Waltham, MA).
+ Open protocol
+ Expand
6

Isolation and Culture of Primary Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human peripheral blood mononuclear cells (PBMCs) were obtained from Immunospot and donors were uncharacterized with respect to sex or age. Primary NK and T cells were isolated from leukoreduction system chambers (LRS chambers) obtained from We Are Blood (Austin, TX); T cells were isolated from three male donors (ages 50, 58, and 71 years) and NK cells were isolated from two 49 year old female donors and a 57 year old male donor. Primary NK cells, primary T cells, HEK293T, Jurkat, and NK-92 cells were maintained at 37°C, 5% v/v CO2 in a humidified incubator. HEK293T cells were maintained in DMEM (Corning) supplemented with 10% FBS (Sigma) and 1% Penicillin-Streptomycin (Corning). Jurkat cells were cultured in RPMI 1640 (Sigma), 10% FBS (Sigma), 1% Penicillin-Streptomycin. NK-92 cells were cultured in NK media; Alpha MEM without nucleosides (GIBCO) with 2 mM L-glutamine (Fisher), 1.5 g/l sodium bicarbonate (Sigma), 0.2 mM inositol (Sigma), 0.1 mM 2-mercaptoethanol, 0.02 mM folic acid (Fisher), 100U/ml recombinant IL-2 (Peprotech), 12.5% horse serum (GIBCO) and 12.5% FBS (Corning).
+ Open protocol
+ Expand
7

Isolation and Culture of Primary Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human peripheral blood mononuclear cells (PBMCs) were obtained from Immunospot and donors were uncharacterized with respect to sex or age. Primary NK and T cells were isolated from leukoreduction system chambers (LRS chambers) obtained from We Are Blood (Austin, TX); T cells were isolated from three male donors (ages 50, 58, and 71 years) and NK cells were isolated from two 49 year old female donors and a 57 year old male donor. Primary NK cells, primary T cells, HEK293T, Jurkat, and NK-92 cells were maintained at 37°C, 5% v/v CO2 in a humidified incubator. HEK293T cells were maintained in DMEM (Corning) supplemented with 10% FBS (Sigma) and 1% Penicillin-Streptomycin (Corning). Jurkat cells were cultured in RPMI 1640 (Sigma), 10% FBS (Sigma), 1% Penicillin-Streptomycin. NK-92 cells were cultured in NK media; Alpha MEM without nucleosides (GIBCO) with 2 mM L-glutamine (Fisher), 1.5 g/l sodium bicarbonate (Sigma), 0.2 mM inositol (Sigma), 0.1 mM 2-mercaptoethanol, 0.02 mM folic acid (Fisher), 100U/ml recombinant IL-2 (Peprotech), 12.5% horse serum (GIBCO) and 12.5% FBS (Corning).
+ Open protocol
+ Expand
8

Quantitative Analysis of Vitamins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thiamine hydrochloride (98.5–101.5%), Riboflavin (98%), Nicotinamide (98%), D-biotin (99%), Folic acid (99%) and cyanocobalamin (99%) were purchased from Fisher (Germany). Vitamins B5 (Pantothenic acid) and B6 (Pyridoxine hydrochloride) were purchased from Chem-Lab (Zedelgem, Belgium) and Fluorochem (United Kingdom) respectively. HPLC grade methanol, acetonitrile, chloroform (≥99.9%, containing amylenes as stabilizer) and salts for preparing the buffer solution were supplied by Sigma-Aldrich (Steinheim, Germany). Water used throughout the analyses was from a Millipore system.
+ Open protocol
+ Expand
9

Layer-by-Layer Preparation of Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Raltitrexed, and poly-l-lysine hydrochloride (PLL, 15–30 kDa) were purchased from Sigma Aldrich. Folic acid was purchased from Fisher Scientific. All LbL methods were carried out in Milli-Q water from a Milli-Q source. KR2i TFF system was purchased from Spectrum Laboratories (Repligen, Waltham, MA, USA).
+ Open protocol
+ Expand
10

Generating NKp46 Isoform Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
NKp46 full length, i.e., domain 1+ (isoform a; matching NM_004829.5) and NKp46-D2, i.e., domain 1 (isoform d; matching NM_001242356.1) cDNA were N-terminal FLAG-tagged and cloned into pBMN-IRES-GFP retroviral vector. NK-92 cells (ATCC CRL-2407), derived from human NK cell leukemia were then transduced with the constructs to produce NK-92-NKp46-Full (NK92-46Full) and NK-92-NKp46-D2 (NK92-46D2) cell lines, respectively. Retroviral transduction was performed as previously described (21 (link)–24 (link)). NK-92 cell lines were then grown in Alpha-MEM medium (Gibco, Life Technologies) supplemented with 10% horse serum, 10% FBS, 0.2 mM myo-inositol (Sigma), 0.1 mM β-mercaptoethanol (Sigma), 0.02 mM folic acid (Fisher Scientific), 100 IU/mL of recombinant human IL-2 (PeproTech), and 1% penicillin/streptomycin (Life Technologies). HEK293T, SV40 large T Ag-transfected HEK293 cells (CRL-11268) were used as target cell lines. HEK293T cells were cultured in DMEM (Gibco, Life Technologies) medium supplemented with 10% FBS and 1% penicillin/streptomycin. Cell lines were grown in a 5% CO2 humidified 37°C incubator.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!